# AMBRISENTAN
> **ANDA208354** · Abbreviated New Drug Application (Generic) · Sponsor: SIGMAPHARM LABS LLC · Approved 2019-04-10
## Drug
- **FDA Application Number:** ANDA208354
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AMBRISENTAN
- **Generic name:** AMBRISENTAN
- **Active ingredients:** AMBRISENTAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SIGMAPHARM LABS LLC
- **Manufacturer:** Sigmapharm Laboratories, LLC
- **First approval:** 2019-04-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208354)
---
*MORVS · CC0 1.0*